Literature DB >> 7168488

Neurological complications of sickle cell anemia.

S A Sarnaik, J M Lusher.   

Abstract

A variety of neurological complications occur with sickle cell hemoglobinopathy. The most striking and most common is cerebral infarction. It is also the most devastating. Because of the high recurrence rate in untreated patients, cerebral infarction is the most debilitating neurological complication. The observed frequency varies from 6% to as high as 34% in different reports. The pathogenesis, clinical features, and demography are discussed. Diagnostic procedures should include a spinal tap to rule out potentially treatable lesions. CT scan and cerebral angiography may also be helpful in certain cases. Transfusion therapy remains the mainstay of management in the acute phase of cerebral infarction. There is considerable evidence to indicate that long-term transfusion programs are effective in the prevention of recurrences. Intracranial hemorrhage, spinal cord infarction, isolated neuropathies due to anatomical proximity to infarcted bones, lead neuropathy, auditory problems, and ocular manifestations are other neurological problems which can affect patients with sickle cell disease.

Entities:  

Mesh:

Year:  1982        PMID: 7168488     DOI: 10.1097/00043426-198224000-00006

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  9 in total

1.  Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability.

Authors:  A Y Kandeel; R A Zimmerman; K Ohene-Frempong
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

2.  Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.

Authors:  M E Horn; M C Dick; B Frost; L R Davis; A J Bellingham; C E Stroud; J W Studd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

Review 3.  Subarachnoid hemorrhage in sickle cell disease.

Authors:  J Carey; Y Numaguchi; J Nadell
Journal:  Childs Nerv Syst       Date:  1990-01       Impact factor: 1.475

4.  The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy.

Authors:  Samuel A Adegoke; Emmanuel A Abioye-Kuteyi; Ernest O Orji
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

Review 5.  Myelopathy in sickle cell disease: a case-oriented review.

Authors:  Igor Vilela Brum; Guilherme Diogo Silva; Diego Sant'Ana Sodre; Felipe Melo Nogueira; Samira Luisa Dos Apostolos Pereira; Luiz Henrique Martins Castro
Journal:  Spinal Cord Ser Cases       Date:  2021-09-25

6.  Incidence of overt and covert neurological damage in children with sickle cell disease.

Authors:  P C Hindmarsh; M Brozovic; C G Brook; S C Davies
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

7.  Adverse neurological outcomes in Nigerian children with sickle cell disease.

Authors:  I A Lagunju; B J Brown
Journal:  Int J Hematol       Date:  2012-11-06       Impact factor: 2.490

Review 8.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr

9.  A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.

Authors:  April Edwards; E Leila Jerome Clay; Valerie Jewells; Stacie Adams; Regina D Crawford; Rupa Redding-Lallinger
Journal:  J Med Case Rep       Date:  2013-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.